Clinical Trial Update: ARB, ACEi, DRi Effects on COVID-19 Course Disease

View source ↗

Summary

A completed clinical trial investigating the effects of ARB, ACEi, and DRi on the course of COVID-19 in patients with hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: Medical Practice Prof D. Ivanov | Conditions: Hypertension, COVID-19 | Status: COMPLETED | Results posted: 2022-02-18